Medical Properties Trust: Cheap Enough To Watch Closely, Not Yet Enough To Buy
Medical Properties Trust (MPT) shows operational improvements, but macro and balance sheet risks keep me at a Hold rating. Transitioned assets are stabilizing, with Quorum and HonorHealth at stabilized rents and HSA ramping toward full contractual rent by Q4 2026. EBITDARM coverage remains steady at ~2.5x, and post-acute operators demonstrate strong YoY improvements, supporting portfolio stability.
Medical Properties Trust, Inc. (MPT) Q1 2026 Earnings Call Transcript
Medical Properties Trust, Inc. (MPT) Q1 2026 Earnings Call Transcript
Medical Properties Trust: New Tenant Risk Meets Promising Recovery Cadence - Contrarian Buy
Medical Properties Trust faces new risks from HSA, a tenant that comprises 7.2% of the FQ4'25 revenues, with the tenant's ongoing litigation contributing to the REIT's recent selloff. Despite the uncertain macroeconomic risks, the REIT's improving portfolio/balance sheet performance signals resilience, aided by the secure AFFO payout ratio at 50%. H2'26 may also bring forth notably improved top/bottom lines once more of MPT's new tenants commence rental payments, aided by the legal proceeds from Prospects' bankruptcy proceedings.
Medical Properties Trust: High Safety Margin
Medical Properties Trust has stabilized operations and fully supported its dividend with normalized FFO in 2025. MPT addressed Prospect Medical bankruptcy exposure, securing a 15-year lease for six California hospitals expected to yield $45 million in annual cash rent by late 2026. Dividend coverage is robust, with Q4 normalized FFO of $0.18 per share versus a $0.09 per share dividend, yielding a 200% coverage ratio.
Medical Properties Trust: 2 Reasons Not To Follow The Short Sellers
Medical Properties Trust delivered Q4 results beating consensus, with FFO rebounding to $0.18/share and revenue up 16.6% YoY. Yet the stock became one of the most shorted REIT stocks in the quarter. Short sellers overstated issues surrounding its liquidity, leverage, and earnings stability post-tenant restructurings.
Medical Properties Trust: The Bear Case Is Getting Dangerous As Cash Flow Turns Up Fast
Medical Properties Trust: The Bear Case Is Getting Dangerous As Cash Flow Turns Up Fast
Medical Properties Q4 NFFO Beat Estimates, Revenues Rise Y/Y
MPT tops Q4 NFFO and revenue estimates as rent billed jumps, while high interest expenses pressure results.
Medical Properties Trust: Recent Improvements, 12.5% Dividend Hike, And Buybacks Are Signs Of Life (Rating Upgrade)
Medical Properties Trust shows modest operational improvement, but high leverage and questionable tenant credit quality keep me at a strong sell. Despite a 12.5% dividend hike and a $150M buyback program, MPT's turnaround remains uncertain and likely at least 12–24 months away. Q3 results revealed mixed performance: revenue was up year-over-year but down sequentially, with ongoing rent collection and tenant bankruptcy challenges.
Medical Properties (MPT) Q4 FFO and Revenues Surpass Estimates
Medical Properties (MPT) came out with quarterly funds from operations (FFO) of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.18 per share a year ago.
